BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9203050)

  • 1. Progestin-androgen combination regimens for male contraception.
    Meriggiola MC; Bremner WJ
    J Androl; 1997; 18(3):240-4. PubMed ID: 9203050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contraceptive efficacy and adverse effects of testosterone enanthate in Thai men.
    Sukcharoen N; Aribarg A; Kriangsinyos R; Chanprasit Y; Ngeamvijawat J
    J Med Assoc Thai; 1996 Dec; 79(12):767-73. PubMed ID: 9071080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher testosterone dose impairs sperm suppression induced by a combined androgen-progestin regimen.
    Meriggiola MC; Costantino A; Bremner WJ; Morselli-Labate AM
    J Androl; 2002; 23(5):684-90. PubMed ID: 12185103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
    Meriggiola MC; Bremner WJ; Costantino A; Di Cintio G; Flamigni C
    Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations.
    Anawalt BD; Bebb RA; Bremner WJ; Matsumoto AM
    J Androl; 1999; 20(3):407-14. PubMed ID: 10386821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates of suppression and recovery of human sperm output in testosterone-based hormonal contraceptive regimens.
    Ly LP; Liu PY; Handelsman DJ
    Hum Reprod; 2005 Jun; 20(6):1733-40. PubMed ID: 15860500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Male contraception in 1987].
    Silvestre L; Varin C; Bouchard P
    Rev Prat; 1987 Sep; 37(38):2302-11. PubMed ID: 3310192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modification of fertility of the male by antiandrogens].
    Moltz L; Neumann F; Hammerstein J
    Gynakologe; 1980 Mar; 13(1):18-32. PubMed ID: 6219927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone/progestin regimens: a realistic option for male contraception?
    Amory JK
    Curr Opin Investig Drugs; 2004 Oct; 5(10):1025-30. PubMed ID: 15535423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in research into new methods of fertility regulation for men.
    Prog Hum Reprod Res; 1995; (33):2. PubMed ID: 12289975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
    Meriggiola MC; Bremner WJ; Paulsen CA; Valdiserri A; Incorvaia L; Motta R; Pavani A; Capelli M; Flamigni C
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3018-23. PubMed ID: 8768868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. V. Localization of higher 5 alpha-reductase activity to the reproductive tract in oligozoospermic men administered supraphysiological doses of testosterone.
    Anderson RA; Kelly RW; Wu FC
    J Androl; 1997; 18(4):366-71. PubMed ID: 9283948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial.
    Anawalt BD; Amory JK; Herbst KL; Coviello AD; Page ST; Bremner WJ; Matsumoto AM
    J Androl; 2005; 26(3):405-13. PubMed ID: 15867009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Male hormonal contraception.
    Wang C; Swerdloff RS
    Am J Obstet Gynecol; 2004 Apr; 190(4 Suppl):S60-8. PubMed ID: 15105800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride.
    Kinniburgh D; Anderson RA; Baird DT
    J Androl; 2001; 22(1):88-95. PubMed ID: 11191092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal male contraception: progress and prospects for the 21st century.
    Handelsman DJ
    Aust N Z J Med; 1995 Dec; 25(6):808-16. PubMed ID: 8770357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depot testosterone with etonogestrel implants result in induction of azoospermia in all men for long-term contraception.
    Brady BM; Walton M; Hollow N; Kicman AT; Baird DT; Anderson RA
    Hum Reprod; 2004 Nov; 19(11):2658-67. PubMed ID: 15333595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Male contraception.
    Wang C; Swerdloff RS
    Best Pract Res Clin Obstet Gynaecol; 2002 Apr; 16(2):193-203. PubMed ID: 12041962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative progestational and androgenic activity of four progestins used for male hormonal contraception assessed in vitro in relation to their ability to suppress LH secretion in the castrate male rat.
    Attardi BJ; Koduri S; Hild SA
    Mol Cell Endocrinol; 2010 Oct; 328(1-2):16-21. PubMed ID: 20599585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Male contraception: expanding reproductive choice.
    Rajalakshmi M
    Indian J Exp Biol; 2005 Nov; 43(11):1032-41. PubMed ID: 16313066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.